Is the Ki-67 labelling index ready for clinical use?

Ann Oncol. 2011 Mar;22(3):500-502. doi: 10.1093/annonc/mdq732.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use
  • Biomarkers, Tumor / metabolism*
  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / pathology
  • Female
  • Humans
  • Ki-67 Antigen / metabolism*
  • Molecular Diagnostic Techniques
  • Neoplasms, Hormone-Dependent / diagnosis*
  • Neoplasms, Hormone-Dependent / drug therapy
  • Neoplasms, Hormone-Dependent / pathology
  • Predictive Value of Tests
  • Staining and Labeling
  • Tamoxifen / therapeutic use
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Hormonal
  • Biomarkers, Tumor
  • Ki-67 Antigen
  • Tamoxifen